The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Open accessAbstract
Purpose: To provide evidence-based recommendations to practicing physicians and others on the management of malignant pleural mesothelioma. Methods: ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary, pathology, imaging, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1990 through 2017. Outcomes of interest included survival, disease-free or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. Results: The literature search identified 222 relevant studies to inform the evidence base for this guideline. Recommendations: Evidence-based recommendations were developed for diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy, and multimodality therapy in patients with malignant pleural mesothelioma. Additional information is available at www.asco.org/thoracic-cancer-guidelines and www.asco.org/guidelineswiki .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Zalcman, G., Mazieres, J., Margery, J., Greillier, L., Audigier-Valette, C., Moro-Sibilot, D., Molinier, O., Corre, R., Monnet, I., Gounant, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01238-6 · Cited by 968
Bueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
Self-citationTreasure, T., Lang-Lazdunski, L., Waller, D., Bliss, J. M., Tan, C., Entwisle, J., Snee, M., O'Brien, M., Thomas, G., Senan, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70149-8 · Cited by 708
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
Byrne, M. J., & Nowak, A. K. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh059 · Cited by 645
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Hesketh, P. J., Kris, M. G., Basch, E., Bohlke, K., Barbour, S. Y., Clark-Snow, R. A., Danso, M. A., Dennis, K., Dupuis, L. L., Dusetzina, S. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.4789 · Cited by 628
van Meerbeeck, J. P., Gaafar, R., Manegold, C., Van Klaveren, R. J., Van Marck, E. A., Vincent, M., Legrand, C., Bottomley, A., Debruyne, C., & Giaccone, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.20005.14.589 · Cited by 617
Patient-clinician communication: American Society of Clinical Oncology consensus guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2311 · Cited by 610
Paice, J. A., Portenoy, R., Lacchetti, C., Campbell, T., Cheville, A., Citron, M., Constine, L. S., Cooper, A., Glare, P., Keefe, F., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.5206 · Cited by 599
Rusch, V. W., Rosenzweig, K., Venkatraman, E., Leon, L., Raben, A., Harrison, L., Bains, M. S., Downey, R. J., & Ginsberg, R. J. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.116560 · Cited by 493
Self-citationHusain, A. N., Colby, T., Ordonez, N., Krausz, T., Attanoos, R., Beasley, M. B., Borczuk, A. C., Butnor, K., Cagle, P. T., Chirieac, L. R., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0214-oa · Cited by 473
Krug, L. M., Pass, H. I., Rusch, V. W., Kindler, H. L., Sugarbaker, D. J., Rosenzweig, K. E., Flores, R., Friedberg, J. S., Pisters, K., Monberg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3943 · Cited by 467
Self-citationBoutin, C., Rey, F., & Viallat, J.-R. (1995) · Chest · doi:10.1378/chest.108.3.754 · Cited by 464
RECIST revisited: A review of validation studies on tumour assessment
Therasse, P., Eisenhauer, E. A., & Verweij, J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.026 · Cited by 422
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
Allen, A. M., Czerminska, M., Jänne, P. A., Sugarbaker, D. J., Bueno, R., Harris, J. R., Court, L., & Baldini, E. H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.012 · Cited by 351
Self-citationMaskell, N., Gleeson, F., & Davies, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13079-6 · Cited by 345
Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study
Byrne, M. J., Davidson, J. A., Musk, A. W., Dewar, J., van Hazel, G., Buck, M., de Klerk, N. H., & Robinson, B. W. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.25 · Cited by 334
Weder, W., Stahel, R. A., Bernhard, J., Bodis, S., Vogt, P., Ballabeni, P., Lardinois, D., Betticher, D., Schmid, R., Stupp, R., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm093 · Cited by 320
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
Rusch, V. W., Giroux, D., Kennedy, C., Ruffini, E., Cangir, A. K., Rice, D., Pass, H., Asamura, H., Waller, D., Edwards, J., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826915f1 · Cited by 308
Self-citationAmerican Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04187.x · Cited by 308
Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma
Ceresoli, G. L., Zucali, P. A., Favaretto, A. G., Grossi, F., Bidoli, P., Del Conte, G., Ceribelli, A., Bearz, A., Morenghi, E., Cavina, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3190 · Cited by 296
de Perrot, M., Feld, R., Cho, B. C. J., Bezjak, A., Anraku, M., Burkes, R., Roberts, H., Tsao, M. S., Leighl, N., Keshavjee, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5604 · Cited by 291
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
Heelan, R. T., Rusch, V. W., Begg, C. B., Panicek, D. M., Caravelli, J. F., & Eisen, C. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.172.4.10587144 · Cited by 289
Self-citationRice, D., Rusch, V., Pass, H., Asamura, H., Nakano, T., Edwards, J., Giroux, D. J., Hasegawa, S., Kernstine, K. H., Waller, D., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182208e3f · Cited by 269
Self-citationRusch, V. W., Piantadosi, S., & Holmes, E. C. (1991) · PubMed · Cited by 264
Self-citationA systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma
Cao, C., Tian, D., Park, J., Allan, J., Pataky, K. A., & Yan, T. D. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.026 · Cited by 261
Muers, M. F., Stephens, R. J., Fisher, P., Darlison, L., Higgs, C. M., Lowry, E., Nicholson, A. G., O'Brien, M., Peake, M., Rudd, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60727-8 · Cited by 260
Kindler, H. L., Karrison, T. G., Gandara, D. R., Lu, C., Krug, L. M., Stevenson, J. P., Jänne, P. A., Quinn, D. I., Koczywas, M. N., Brahmer, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5869 · Cited by 257
Self-citationSantoro, A., O'Brien, M. E., Stahel, R. A., Nackaerts, K., Baas, P., Karthaus, M., Eberhardt, W., Paz-Ares, L., Sundstrom, S., Liu, Y., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31817c73d6 · Cited by 255
Scagliotti, G. V., Shin, D.-M., Kindler, H. L., Vasconcelles, M. J., Keppler, U., Manegold, C., Burris, H., Gatzemeier, U., Blatter, J., Symanowski, J. T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.122 · Cited by 251
Self-citationThe role of extrapleural pneumonectomy in malignant pleural mesothelioma
Rusch, V. W., Piantadosi, S., & Holmes, E. C. (1991) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36577-8 · Cited by 250
Self-citationVan Schil, P. E., Baas, P., Gaafar, R., Maat, A. P., Van de Pol, M., Hasan, B., Klomp, H. M., Abdelrahman, A. M., Welch, J., & van Meerbeeck, J. P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00039510 · Cited by 243
Mansfield, A. S., Roden, A. C., Peikert, T., Sheinin, Y. M., Harrington, S. M., Krco, C. J., Dong, H., & Kwon, E. D. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000177 · Cited by 238
Jassem, J., Ramlau, R., Santoro, A., Schuette, W., Chemaissani, A., Hong, S., Blatter, J., Adachi, S., Hanauske, A., & Manegold, C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9887 · Cited by 231
Hollevoet, K., Reitsma, J. B., Creaney, J., Grigoriu, B. D., Robinson, B. W., Scherpereel, A., Cristaudo, A., Pass, H. I., Nackaerts, K., Rodríguez Portal, J. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6671 · Cited by 230
Self-citationFlores, R. M., Zakowski, M., Venkatraman, E., Krug, L., Rosenzweig, K., Dycoco, J., Lee, C., Yeoh, C., Bains, M., & Rusch, V. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815608d9 · Cited by 229
Self-citationA multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
Nowak, A. K., Byrne, M. J., Williamson, R., Ryan, G., Segal, A., Fielding, D., Mitchell, P., Musk, A. W., & Robinson, B. W. S. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600505 · Cited by 225
Rintoul, R. C., Ritchie, A. J., Edwards, J. G., Waller, D. A., Coonar, A. S., Bennett, M., Lovato, E., Hughes, V., Fox-Rushby, J. A., & Sharples, L. D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60418-9 · Cited by 224
Richards, W. G., Zellos, L., Bueno, R., Jaklitsch, M. T., Jänne, P. A., Chirieac, L. R., Yeap, B. Y., Dekkers, R. J., Hartigan, P. M., Capalbo, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6813 · Cited by 223
Self-citationKrug, L. M., Kindler, H. L., Calvert, H., Manegold, C., Tsao, A. S., Fennell, D., Öhman, R., Plummer, R., Eberhardt, W. E. E., Fukuoka, K., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70056-2 · Cited by 215
Self-citationRusch, V. W., Chansky, K., Kindler, H. L., Nowak, A. K., Pass, H. I., Rice, D. C., Shemanski, L., Galateau-Sallé, F., McCaughan, B. C., Nakano, T., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.09.124 · Cited by 207
Self-citationPhase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma
Steele, J. P. C., Shamash, J., Evans, M. T., Gower, N. H., Tischkowitz, M. D., & Rudd, R. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3912 · Cited by 203
Stahel, R. A., Riesterer, O., Xyrafas, A., Opitz, I., Beyeler, M., Ochsenbein, A., Früh, M., Cathomas, R., Nackaerts, K., Peters, S., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00208-9 · Cited by 202
Meyerhoff, R. R., Yang, C.-F. J., Speicher, P. J., Gulack, B. C., Hartwig, M. G., D'Amico, T. A., Harpole, D. H., & Berry, M. F. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.01.043 · Cited by 199
Pass, H. I., Temeck, B. K., Kranda, K., Thomas, G., Russo, A., Smith, P., Friauf, W., & Steinberg, S. M. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02303746 · Cited by 197
Self-citationTaioli, E., Wolf, A. S., & Flores, R. M. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.09.056 · Cited by 191
Rimner, A., Zauderer, M. G., Gomez, D. R., Adusumilli, P. S., Parhar, P. K., Wu, A. J., Woo, K. M., Shen, R., Ginsberg, M. S., Yorke, E. D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.2675 · Cited by 190
Self-citationShiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Metintas, M., Ak, G., Dundar, E., Yildirim, H., Ozkan, R., Kurt, E., Erginel, S., Alatas, F., & Metintas, S. (2010) · Chest · doi:10.1378/chest.09-0884 · Cited by 181
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma
O’Rourke, N., Garcia, J. C., Paul, J., Lawless, C., McMenemin, R., & Hill, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.022 · Cited by 180
Bydder, S., Phillips, M., Joseph, D. J., Cameron, F., Spry, N. A., DeMelker, Y., & Musk, A. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601957 · Cited by 179
Tilleman, T. R., Richards, W. G., Zellos, L., Johnson, B. E., Jaklitsch, M. T., Mueller, J., Yeap, B. Y., Mujoomdar, A. A., Ducko, C. T., Bueno, R., et al. (2009) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2009.02.046 · Cited by 173
Self-citationSugarbaker, D. J., Gill, R. R., Yeap, B. Y., Wolf, A. S., DaSilva, M. C., Baldini, E. H., Bueno, R., & Richards, W. G. (2013) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.12.037 · Cited by 166
Self-citationLang-Lazdunski, L., Bille, A., Lal, R., Cane, P., McLean, E., Landau, D., Steele, J., & Spicer, J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824ab6c5 · Cited by 166
Hwang, H. C., Sheffield, B. S., Rodriguez, S., Thompson, K., Tse, C. H., Gown, A. M., & Churg, A. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000529 · Cited by 166
Clive, A. O., Taylor, H., Dobson, L., Wilson, P., de Winton, E., Panakis, N., Pepperell, J., Howell, T., Stewart, S. A., Penz, E., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30095-x · Cited by 166
Manegold, C., Symanowski, J., Gatzemeier, U., Reck, M., von Pawel, J., Kortsik, C., Nackaerts, K., Lianes, P., & Vogelzang, N. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi187 · Cited by 160
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
van Haarst, J. M. W., Baas, P., Manegold, C., Schouwink, J. H., Burgers, J. A., de Bruin, H. G., Mooi, W. J., van Klaveren, R. J., de Jonge, M. J. A., & van Meerbeeck, J. P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600118 · Cited by 159
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma
Gupta, V., Mychalczak, B., Krug, L., Flores, R., Bains, M., Rusch, V. W., & Rosenzweig, K. E. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.041 · Cited by 159
Self-citationTaioli, E., Wolf, A. S., Camacho-Rivera, M., Kaufman, A., Lee, D.-S., Nicastri, D., Rosenzweig, K., & Flores, R. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145039 · Cited by 158
Rice, D. C., Smythe, W. R., Liao, Z. X., Guerrero, T. M., Chang, J. Y., McAleer, M. F., Jeter, M. D., Correa, A. M., Vaporciyan, A. A., Liu, H. H., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.011 · Cited by 157
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
Stebbing, J., Powles, T. B., McPherson, K., Shamash, J., Wells, P., Sheaff, M. T., Slater, S., Rudd, R., Fennell, D. A., & Steele, J. P. C. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.04.001 · Cited by 155
Pleural Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma
Rosenzweig, K. E., Zauderer, M. G., Laser, B. S., Krug, L. M., Yorke, E. D., Sima, C. S., Rimner, A., Flores, R. M., & Rusch, V. W. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.027 · Cited by 152
Self-citationComparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
Creaney, J., Dick, I. M., Meniawy, T. M., Leong, S. L., Leon, J. S., Demelker, Y., Segal, A., Musk, A. W., Lee, G., Skates, S. J., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205205 · Cited by 146
Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma
Yajnik, S. V., Rosenzweig, K. E., Mychalczak, B. R., Krug, L. M., Flores, R. M., Hong, L. X., & Rusch, V. W. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00287-6 · Cited by 145
Self-citationBovolato, P., Casadio, C., Billè, A., Ardissone, F., Santambrogio, L., Ratto, G. B., Garofalo, G., Bedini, A. V., Garassino, M. C., Porcu, L., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000064 · Cited by 141
Castagneto, B., Botta, M., Aitini, E., Spigno, F., Degiovanni, D., Alabiso, O., Serra, M., Muzio, A., Carbone, R. G., Buosi, R., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm501 · Cited by 141
de Perrot, M. E., Feld, R. D., Leighl, N. B., Hope, A. J., Waddell, T. K., Keshavjee, S. H., & Cho, J. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.09.129 · Cited by 138
Kadota, K., Suzuki, K., Sima, C. S., Rusch, V. W., Adusumilli, P. S., & Travis, W. D. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318211127a · Cited by 137
Self-citationA Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
Cao, C. Q., Yan, T. D., Bannon, P. G., & McCaughan, B. C. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ed0489 · Cited by 136
Cho, J., Feld, R., Leighl, N. B., Opitz, I., Anraku, M., Tsao, M., Hwang, D. M., Hope, A. J., & de Perrot, M. E. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000078 · Cited by 129
Fizazi, K. S., Doubre, H., Chevalier, T. L., Riviere, A., Viala, J., Daniel, C., Robert, L., Barthélemy, P., Fandi, A., & Ruffiè, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.123 · Cited by 129
Friedberg, J. S., Simone, C. B., Culligan, M. J., Barsky, A. R., Doucette, A. G., McNulty, S., Hahn, S. M., Alley, E. W., Sterman, D. H., GLATSTEIN, E. J., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.08.071 · Cited by 128
Self-citationvan Klaveren, R. V., Aerts, J., de Bruin, H. D., Giaccone, G., Manegold, C., & van Meerbeeck, J. V. (2004) · Lung Cancer · doi:10.1016/s0169-5002(03)00292-7 · Cited by 126
Gomez, D. R., Hong, D. S., Allen, P. K., Welsh, J. S., Mehran, R. J., Tsao, A. S., Liao, Z. X., Bilton, S. D., Komaki, R. K., & Rice, D. C. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827740f0 · Cited by 123
O'Brien, M. E. R., Watkins, D. J., Ryan, C., Priest, K., Corbishley, C. M., Norton, A., Ashley, S., Rowell, N. P., & Sayer, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj073 · Cited by 123
de Graaf-Strukowska, L., van der Zee, J., van Putten, W., & Senan, S. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00409-x · Cited by 121
Ceresoli, G. L., Castagneto, B., Zucali, P. A., Favaretto, A. G., Mencoboni, M., Grossi, F., Cortinovis, D. L., Conte, G. D., Ceribelli, A., Bearz, A., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604442 · Cited by 119
Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma
Zauderer, M. G., Kass, S. L., Woo, K. M., Sima, C. S., Ginsberg, M. S., & Krug, L. M. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.03.006 · Cited by 117
Favaretto, A. G., Aversa, S. M. L., Paccagnella, A., Manzini, V. D. P., Palmisano, V., Oniga, F., Stefani, M., Rea, F., Bortolotti, L., Loreggian, L., et al. (2003) · Cancer · doi:10.1002/cncr.11405 · Cited by 113
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
Jackman, D. M., Kindler, H. L., Yeap, B. Y., Fidias, P. M., Salgia, R., Lucca, J. V., Morse, L. K., Ostler, P. A., Johnson, B. E., & Janne, P. A. (2008) · Cancer · doi:10.1002/cncr.23617 · Cited by 110
Self-citationCeresoli, G. L., Zucali, P. A., Mencoboni, M., Botta, M., Grossi, F., Cortinovis, D. L., Zilembo, N., Ripa, C., Tiseo, M., Favaretto, A. G., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.368 · Cited by 107
Pass, H. I., Giroux, D. J., Kennedy, C. W., Ruffini, E., Cangır, A., Rice, D., Asamura, H., Waller, D. A., Edwards, J. G., Weder, W., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000181 · Cited by 107
Self-citationBurt, B. M., Cameron, R. B., Mollberg, N. M., Kosinski, A. S., Schipper, P. H., Shrager, J. B., & Vigneswaran, W. T. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.03.011 · Cited by 106
Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
Frauenfelder, T., Tutic, M., Weder, W., Götti, R. P., Stahel, R. A., Seifert, B., & Opitz, I. (2011) · European Respiratory Journal · doi:10.1183/09031936.00146110 · Cited by 105
Andrici, J., Sheen, A., Sioson, L., Wardell, K. L., Clarkson, A., Watson, N., Ahadi, M. S., Farzin, M., Toon, C. W., & Gill, A. J. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.87 · Cited by 105
Righi, L., Duregon, E., Vatrano, S., Izzo, S., Giorcelli, J., Rondón‐Lagos, M., Ascoli, V., Ruffini, E., Ventura, L., Volante, M., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.020 · Cited by 105
Ried, M., Potzger, T., Braune, N., Neu, R., Zausig, Y. A., Schalke, B. C. G., Diez, C., & Hofmann, H. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs418 · Cited by 104
Ordóǹez, N. G. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.05.014 · Cited by 103
Zucali, P. A., Simonelli, M., Michetti, G., Tiseo, M., Ceresoli, G. L., Collovà, E., Follador, A., Dico, M. L., Moretti, A., Vincenzo, F. D., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.08.011 · Cited by 103
Park, E., Sandrini, A., Yates, D. H., Creaney, J., Robinson, B. W. S., Thomas, P. S., & Johnson, A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-258oc · Cited by 102
Nowak, A. K., Millward, M., Creaney, J., Francis, R. J., Dick, I. M., Hasani, A., van der Schaaf, A. A., Segal, A., Musk, A. W., & Byrne, M. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825f22ee · Cited by 102
Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma
Zucali, P. A., Ceresoli, G. L., Garassino, I. M. G., Vincenzo, F. D., Cavina, R., Campagnoli, E., Cappuzzo, F., Salamina, S., Parra, H. J. S., & Santoro, A. (2008) · Cancer · doi:10.1002/cncr.23337 · Cited by 100
Liu, F., Zhao, B., Krug, L. M., Ishill, N. M., Lim, R., Guo, P., Gorski, M., Flores, R. M., Moskowitz, C. S., Rusch, V. W., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181dd0ef1 · Cited by 97
Self-citationDowell, J. E., Dunphy, F., Taub, R. N., Gerber, D. E., Ngov, L.-K., Yan, J., Xie, Y., & Kindler, H. L. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.05.111 · Cited by 96
Self-citationDiagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
Hollevoet, K., Nackaerts, K., Thimpont, J., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1020oc · Cited by 95
Pleural Biopsy: A Reliable Method for Determining the Diagnosis But Not Subtype in Mesothelioma
Bueno, R., Reblando, J., Glickman, J. N., et al. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.05.007 · Cited by 94
Self-citationGill, R. R., Richards, W. G., Yeap, B. Y., Matsuoka, S., Wolf, A., Gerbaudo, V. H., Bueno, R., Sugarbaker, D. J., & Hatabu, H. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7015 · Cited by 93
Self-citationKing, J. A., Thatcher, N., Pickering, C., & Hasleton, P. S. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02442.x · Cited by 92
Plathow, C., Staab, A., Schmähl, A., Aschoff, P., ZUNA, I., Pfannenberg, C., Peter, S. H., Eschmann, S. M., & Klopp, M. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181817b3d · Cited by 91
Zellos, L. S., Richards, W. G., Capalbo, L., Jaklitsch, M. T., Chirieac, L. R., Johnson, B. E., Bueno, R., & Sugarbaker, D. J. (2009) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.07.055 · Cited by 88
Self-citationPemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma
van den Bogaert, D. P. M., Pouw, E. M., van Wijhe, G., Vernhout, R. M., Surmont, V. F. M., Hoogsteden, H. C., & van Klaveren, R. J. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31509-4 · Cited by 87
Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma
Baldini, E. H., Richards, W. G., Gill, R. R., Goodman, B. M., Winfrey, O. K., Eisen, H. M., Mak, R. H., Chen, A. B., Kozono, D., Bueno, R., et al. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.10.128 · Cited by 87
Self-citationYan, T. D., Boyer, M. J., Tin, M. M., Wong, D., Kennedy, C. J., McLean, J. M., Bannon, P. G., & McCaughan, B. C. (2009) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.12.045 · Cited by 85
Minatel, E., Trovò, M., Trovò, M., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.10.013 · Cited by 85
Hollevoet, K., Nackaerts, K., Gosselin, R., Wever, W. D., Bosquée, L., Vuyst, P. D., Germonpré, P. R., Kellen, E., Legrand, C., Kishi, Y., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182272294 · Cited by 84
Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial
MacLeod, N. J., Chalmers, A. J., O'Rourke, N., Moore, K., Sheridan, J., McMahon, L., Bray, C. A., Stobo, J., Price, A., Fallon, M., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000499 · Cited by 84
Flores, R. M., Routledge, T., Seshan, V., Dycoco, J., Zakowski, M. F., Hirth, Y., & Rusch, V. W. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.02.069 · Cited by 84
Self-citationFlores, R. M., Riedel, E., Donington, J. S., Alago, W., Ihekweazu, U. N., Krug, L. M., Rosenzweig, K. E., Adusumilli, P. S., Carbone, M., & Pass, H. I. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f1903e · Cited by 81
Self-citationArmato, S. G., Oxnard, G. R., MacMahon, H., Vogelzang, N. J., Kindler, H. L., Kocherginsky, M., & Starkey, A. (2004) · Medical Physics · doi:10.1118/1.1688211 · Cited by 79
Self-citationJo, V. Y., Cibas, E. S., & Pinkus, G. S. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21392 · Cited by 78
Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary
Maziak, D. E., Gagliardi, A. R., Haynes, A. E., Mackay, J. A., & Evans, W. K. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2004.11.003 · Cited by 78
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma
Rusch, V. W., Rusch, V. W., Gill, R., Mitchell, A., Naidich, D., Rice, D. C., Pass, H. I., Kindler, H. L., Perrot, M. D., Friedberg, J., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.06.069 · Cited by 76
Self-citationKatirtzoglou, N., Gkiozos, I., Makrilia, N., Tsaroucha, E., Rapti, A., Stratakos, G., Fountzilas, G., & Syrigos, K. N. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.005 · Cited by 75
Janne, P. A., Wozniak, A. J., Belani, C. P., Keohan, M. L., Ross, H. J., Polikoff, J. A., Mintzer, D. M., Ye, Z., Monberg, M., & Obasaju, C. K. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30351-8 · Cited by 74
Plathow, C., Klopp, M., Thieke, C., Herth, F. J. F., Thomas, A., Schmähl, A., ZUNA, I., & Kauczor, H. (2008) · European Radiology · doi:10.1007/s00330-008-0918-9 · Cited by 74
Self-citationBottomley, A., Gaafa, R., Manegold, C., Burgers, S. J. A., Coens, C., Legrand, C., Vincent, M. D., Giaccone, G., & van Meerbeeck, J. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3027 · Cited by 73
Scorsetti, M., Bignardi, M., Clivio, A., Cozzi, L., Fogliata, A., Lattuada, P., Mancosu, P., Navarria, P., Nicolini, G., Urso, G., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.053 · Cited by 72
Richards, W. G., Godleski, J. J., Yeap, B. Y., et al. (2010) · Cancer · doi:10.1002/cncr.24886 · Cited by 72
Thieke, C., Nicolay, N. H., Sterzing, F., Hoffmann, H., Roeder, F., Safi, S., Debus, J., & Huber, P. E. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0575-5 · Cited by 72
Opitz, I., Friess, M., Kestenholz, P., Schneiter, D., Frauenfelder, T., Nguyen‐Kim, T. D. L., Seifert, B., Hoda, M. A., Klepetko, W., Stahel, R. A., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000661 · Cited by 71
Kinetics of Soluble Mesothelin in Patients with Malignant Pleural Mesothelioma during Treatment
Grigoriu, B. D., Chahine, B., Vachani, A., Gey, T., Conti, M., Sterman, D. H., Marchandise, G., Porte, H., Albelda, S. Μ., & Scherpereel, A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1125oc · Cited by 70
Self-citationTaylor, P., Castagneto, B., Dark, G. G., Marangolo, M., Scagliotti, G. V., van Klaveren, R. J., Labianca, R., Serke, M. H., Schuette, W., van Meerbeeck, J. P., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31817c73ec · Cited by 69
Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma
Cristaudo, A., Bonotti, A., Simonini, S., Vivaldi, A., Guglielmi, G., Ambrosino, N., Chella, A., Lucchi, M., Mussi, A., & Foddis, R. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821e1c08 · Cited by 69
Cisplatin and Gemcitabine in Malignant Pleural Mesothelioma: A Phase II Study
Castagneto, B., Zai, S., Dongiovanni, D., Muzio, A., Bretti, S., Numico, G., & Botta, M. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000144852.75613.56 · Cited by 69
Hasegawa, S., Okada, M., Tanaka, F., Yamanaka, T., Soejima, T., Kamikonya, N., Tsujimura, T., Fukuoka, K., Yokoi, K., & Nakano, T. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-015-0925-1 · Cited by 69
Batırel, H. F., Metintaş, M., Çağlar, H. B., Ak, G., Yumuk, P. F., Yıldızeli, B., & Yüksel, M. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.09.121 · Cited by 69
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
Ghanim, B., Hoda, M. A. R., Klikovits, T., Winter, M.-P., Alimohammadi, A., Grusch, M., Döme, B., Arns, M., Schenk, P., Jakopović, M., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.815 · Cited by 65
The role of radiation therapy in malignant pleural mesothelioma: A systematic review
Ung, Y., Yu, E., Falkson, C. B., et al. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.06.002 · Cited by 64
Modeling of mesothelioma growth demonstrates weaknesses of current response criteria
Oxnard, G. R., Armato, S. G., & Kindler, H. L. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.12.013 · Cited by 64
Self-citationMarkers for the non-invasive diagnosis of mesothelioma: a systematic review
van der Bij, S., Schaake, E. E., Koffijberg, H., Burgers, J. A., de Mol, B. A. J. M., & Moons, K. G. M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.104 · Cited by 64
Lee, C. G. L., Bayman, N., Swindell, R., & Finn, C. F. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.06.014 · Cited by 63
Davis, S. R., TAN, L., & Ball, D. (1994) · Australasian Radiology · doi:10.1111/j.1440-1673.1994.tb00177.x · Cited by 61
Kalmadi, S. R., Rankin, C. J., Kraut, M., Jacobs, A. D., Petrylak, D. P., Adelstein, D. J., Keohan, M. L., Taub, R. N., & Borden, E. C. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.09.018 · Cited by 61
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma
Zucali, P. A., Perrino, M., Lorenzi, E., Ceresoli, G. L., Vincenzo, F. D., Simonelli, M., Gianoncelli, L., Sanctis, R. D., Giordano, L., & Santoro, A. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.011 · Cited by 61
Computerized segmentation and measurement of malignant pleural mesothelioma
Sensakovic, W. F., Armato, S. G., Straus, C. M., Roberts, R. Y., Caligiuri, P., Starkey, A., & Kindler, H. L. (2010) · Medical Physics · doi:10.1118/1.3525836 · Cited by 60
Self-citationRe-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Bearz, A., Talamini, R., Rossoni, G., Santo, A., Manzini, V. D. P., Fasola, G., Rosetti, F., Favaretto, A. G., Gregorc, V., Berretta, M., et al. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-482 · Cited by 59
Sørensen, J. B., Ravn, J. B., Loft, A., et al. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2008.07.050 · Cited by 59
Patel, P. R., Yoo, S., Broadwater, G., Marks, L. B., Miles, E. F., D’Amico, T. A., Harpole, D. H., & Kelsey, C. R. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.11.057 · Cited by 58
What is the best way to diagnose and stage malignant pleural mesothelioma?
Zahid, I., Sharif, S., Routledge, T., & Scarci, M. (2010) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2010.255893 · Cited by 57
Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
Sørensen, J. B., Frank, H., & Palshof, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604421 · Cited by 56
Gill, R. R., Naidich, D. P., Mitchell, A., Ginsberg, M. S., Erasmus, J. J., Armato, S. G., Straus, C. M., Katz, S. I., Patios, D., Richards, W. G., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.04.027 · Cited by 55
Self-citationCreaney, J., Yeoman, D., Musk, A. W., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.02.007 · Cited by 54
Cristaudo, A., Foddis, R., Bonotti, A., Simonini, S., Vivaldi, A., Guglielmi, G., Ambrosino, N., Canessa, P. A., Chella, A., Lucchi, M., et al. (2010) · The International Journal of Biological Markers · doi:10.1177/172460081002500307 · Cited by 54
Mansfield, A. S., Symanowski, J. T., & Peikert, T. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.08.017 · Cited by 53
Chance, W. W., Rice, D. C., Allen, P. K., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.08.343 · Cited by 53
Allen, A. M., Den, R. B., Wong, J. S., Zurakowski, D., Soto, R., Janne, P. A., Zellos, L. S., Bueno, R., Sugarbaker, D. J., & Baldini, E. H. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.02.047 · Cited by 53
Self-citationRadiotherapy for the treatment of pain in malignant pleural mesothelioma: A systematic review
MacLeod, N. J., Price, A., O'Rourke, N., Fallon, M., & Laird, B. J. A. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.004 · Cited by 52
Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma
Vigneswaran, W. T., Kircheva, D. Y., Ananthanarayanan, V., Watson, S., Arif, Q., Celauro, A. D., Kindler, H. L., & Husain, A. N. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.08.063 · Cited by 52
Self-citationTruong, M. T., Viswanathan, C., Godoy, M. B. C., Carter, B. W., & Marom, E. M. (2013) · Seminars in Roentgenology · doi:10.1053/j.ro.2013.03.017 · Cited by 51
Minatel, E., Trovò, M., Bearz, A., Maso, M. D., Baresic, T., Drigo, A., Barresi, L., Furlan, C., Conte, A. D., Bruschi, G., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.029 · Cited by 50
Tonoli, S., Vitali, P., Scotti, V., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.09.025 · Cited by 47
Phase II Trial of Pemetrexed and Gemcitabine in Chemotherapy-Naïve Malignant Pleural Mesothelioma
Janne, P. A., Simon, G. R., Langer, C. J., Taub, R. N., Dowlati, A., Fidias, P., Monberg, M., Obasaju, C. K., & Kindler, H. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7611 · Cited by 47
Self-citationVariability in Mesothelioma Tumor Response Classification
Armato, S. G., Ogarek, J. L., Starkey, A., Vogelzang, N. J., Kindler, H. L., Kocherginsky, M., & MacMahon, H. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.05.0076 · Cited by 46
Self-citationHillerdal, G., Sørensen, J. B., Sundstrøm, S. H., Riska, H., Vikström, A., & Hjerpe, A. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818b174d · Cited by 46
Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case series
Pan, H. Y., Jiang, S., Sutton, J. R., Liao, Z. X., Chance, W. W., Frank, S. J., Zhu, X., Li, H., Fontanilla, H. P., Zhang, X., et al. (2015) · Practical Radiation Oncology · doi:10.1016/j.prro.2014.11.005 · Cited by 44
Fysh, E. T. H., Bielsa, S., Budgeon, C. A., Read, C., Porcel, J. M., Maskell, N. A., & Lee, G. (2014) · CHEST Journal · doi:10.1378/chest.14-1701 · Cited by 43
Kovač, V., Zwitter, M., Rajer, M., Marin, A., Debeljak, A., Smrdel, U., & Vrankar, M. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834d7a1c · Cited by 41
Andreopoulou, E., Ross, P. J., O'Brien, M. E. R., Ford, H. E. R., Priest, K., Eisen, T., Norton, A., Ashley, S., & Smith, I. E. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh356 · Cited by 41
Tsao, A. S., Garland, L. L., Redman, M. W., Kernstine, K. H., Gandara, D. R., & Marom, E. M. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318208c83d · Cited by 40
Chi, A., Liao, Z. X., Nguyen, N. P., Howe, C. L., Gomez, D. R., Jang, S. Y., & Komaki, R. U. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182199819 · Cited by 40
Fibulin-3 as a Diagnostic Biomarker in Patients with Malignant Mesothelioma
Kaya, H., Demir, M., Taylan, M., Sezgı, C., Tanrıkulu, A. Ç., Yılmaz, S., Bayram, M., Kaplan, İ., & Şenyiğit, A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.4.1403 · Cited by 39
Proton Therapy for Malignant Pleural Mesothelioma After Extrapleural Pleuropneumonectomy
Krayenbuehl, J., Hartmann, M., Lomax, A., Kloeck, S., Hug, E. B., & Ciernik, I. F. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.11.006 · Cited by 38
Arnold, D., Hooper, C., Morley, A., White, P., Lyburn, I. D., Searle, J., Darby, M., Hall, T., Hall, D., Rahman, N. M., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.77 · Cited by 36
Bayram, M., Döngel, İ., Akbaş, A., Benli, İ., Akkoyunlu, M. E., & Bakan, N. D. (2013) · Lung · doi:10.1007/s00408-013-9526-9 · Cited by 35
Arrieta, O. G., López-Macías, D., Mendoza-García, V. O., Bacon-Fonseca, L., Munoz-Moñtano, W., Macedo-Pérez, E. O., Muñiz‐Hernández, S., Blake-Cerda, M., & Corona-Cruz, J. F. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2429-5 · Cited by 33
Disease volumes as a marker for patient response in malignant pleural mesothelioma
Labby, Z. E., Nowak, A. K., Dignam, J. J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds535 · Cited by 32
Billè, A., Belcher, E., Raubenheimer, H., Landau, D., Cane, P., Spicer, J. F., & Lang-Lazdunski, L. (2012) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-011-0915-9 · Cited by 31
Tourkantonis, I., Makrilia, N., Ralli, M. L., Alamara, C. V., Nikolaidis, I., Tsimpoukis, S., Charpidou, A. G., Kotanidou, A. N., & Syrigos, K. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181cae90e · Cited by 29
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma
Pass, H. I., Goparaju, C. M. V., Espin‐Garcia, O., Donington, J. S., Carbone, M., Patel, D., Chen, Z., Feld, R. D., Cho, J., Gadgeel, S. M., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.02.006 · Cited by 28
Self-citationWhat is the survival after surgery for localized malignant pleural mesothelioma?†
Gelvez-Zapata, S., Gaffney, D. J., Scarci, M., et al. (2013) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivs542 · Cited by 27
Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.
Blomberg, C., Nilsson, J. A., Holgersson, G., et al. (2015) · PubMed · Cited by 23
Labby, Z. E., Armato, S. G., Dignam, J. J., Straus, C. M., Kindler, H. L., & Nowak, A. K. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828354c8 · Cited by 23
Self-citationOptimization of Response Classification Criteria for Patients with Malignant Pleural Mesothelioma
Labby, Z. E., Armato, S. G., Kindler, H. L., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318269fe21 · Cited by 21
Self-citationThapa, B., Walkiewicz, M., Murone, C., Asadi, K., Deb, S., Barnett, S. A., Knight, S., Mitchell, P. L. R., Liew, D., Watkins, D. N., et al. (2016) · Pathology · doi:10.1016/j.pathol.2016.08.003 · Cited by 19
Lumachi, F., Mazza, F., Ermani, M., Chiara, G. B., & Basso, S. M. M. (2012) · PubMed · Cited by 17
Pain in Malignant Pleural Mesothelioma: A Prospective Characterization Study
MacLeod, N. J., Kelly, C., Stobo, J., McMahon, L., Taggart, D., Fallon, M., & Laird, B. J. A. (2016) · Pain Medicine · doi:10.1093/pm/pnw061 · Cited by 17
Radiologic–pathologic correlation of mesothelioma tumor volume
Armato, S. G., Li, P., Husain, A. N., Straus, C. M., Khanwalkar, A. R., Kindler, H. L., & Vigneswaran, W. T. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2014.11.019 · Cited by 15
Self-citationGalbis, J. M., Mata, M., Guijarro, R., et al. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0617-x · Cited by 14
Hasan, B., Greillier, L., Pallis, A. G., Menis, J., Gaafar, R. M., Sylvester, R. J., Fennell, D. A., Baas, P., Surmont, V. F. M., van Meerbeeck, J. P., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.07.020 · Cited by 13
Lindenmann, J., Matzi, V., Neuboeck, N., Anegg, U., Maier, A., Smolle, J., & Smolle-Juettner, F. M. (2012) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivs465 · Cited by 12
Thies, S., Friess, M., Frischknecht, L., Korol, D., Felley‐Bosco, E., Stahel, R. A., Vrugt, B., Weder, W., Opitz, I., & Soltermann, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139312 · Cited by 12
Palliative Treatment of Malignant Pleural Effusions
Horn, D., Dequanter, D., & Lothaire, P. (2010) · Acta chirurgica Belgica · doi:10.1080/00015458.2010.11680561 · Cited by 7
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Deep learning-based classification of mesothelioma improves prediction of patient outcome
Courtiol, P., Maussion, C., Moarii, M., Pronier, E., Pilcer, S., Sefta, M., Manceron, P., Toldo, S., Zaslavskiy, M., Le Stang, N., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0583-3 · Cited by 544
Scherpereel, A., Mazieres, J., Greillier, L., Lantuejoul, S., Dô, P., Bylicki, O., Monnet, I., Corre, R., Audigier-Valette, C., Locatelli-Sanchez, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30765-4 · Cited by 454
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Carbone, M., Adusumilli, P. S., Alexander, H. R., Baas, P., Bardelli, F., Bononi, A., Bueno, R., Felley‐Bosco, E., Galateau‐Salle, F., Jablons, D., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21572 · Cited by 335
Self-citationERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Scherpereel, A., Opitz, I., Berghmans, T., Psallidas, I., Glatzer, M., Rigau, D., Astoul, P., Bölükbas, S., Boyd, J., Coolen, J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00953-2019 · Cited by 273
Popat, S., Curioni-Fontecedro, A., Dafni, U., Shah, R., O'Brien, M., Pope, A., Fisher, P., Spicer, J., Roy, A., Gilligan, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.009 · Cited by 271
Metadata
- Authors
- Kindler, H. L., Ismaila, N., Armato, S. G., Bueno, R., Hesdorffer, M., Jahan, T., Jones, C. M., Miettinen, M., Pass, H., Rimner, A., Rusch, V., Sterman, D., Thomas, A., & Hassan, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2018-05-01
- Volume
- 36
- Issue
- 13
- Pages
- 1343-1373
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2783708904
- Cited by
- 420
- References
- 188
- FWCI
- 40.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.